| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix constituent, lubricant activity | 2.20e-07 | 4 | 77 | 3 | GO:0030197 | |
| GeneOntologyMolecularFunction | neuroligin family protein binding | 5.48e-07 | 5 | 77 | 3 | GO:0097109 | |
| GeneOntologyMolecularFunction | transcription factor binding | NCOA2 CCNT1 NCOR1 TEAD2 FOXP2 PITX1 PITX2 HCFC1 LRIF1 ZNF568 TP53BP1 HTT | 2.93e-05 | 753 | 77 | 12 | GO:0008134 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 3.95e-04 | 582 | 77 | 9 | GO:0140297 | |
| GeneOntologyMolecularFunction | ion channel regulator activity | 4.08e-04 | 162 | 77 | 5 | GO:0099106 | |
| GeneOntologyMolecularFunction | channel regulator activity | 5.65e-04 | 174 | 77 | 5 | GO:0016247 | |
| GeneOntologyMolecularFunction | transporter regulator activity | 6.10e-04 | 177 | 77 | 5 | GO:0141108 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 1.13e-03 | 417 | 77 | 7 | GO:0061629 | |
| GeneOntologyMolecularFunction | calcium channel regulator activity | 1.19e-03 | 54 | 77 | 3 | GO:0005246 | |
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | 1.25e-03 | 55 | 77 | 3 | GO:0042974 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR51F2 NRXN3 NRXN1 NRXN2 SPN GPR34 OR1L6 ROBO1 ADGRF5 TNFRSF1B ADGRG4 OR51H1 OR1L4 | 1.88e-03 | 1353 | 77 | 13 | GO:0004888 |
| GeneOntologyMolecularFunction | protein domain specific binding | 1.90e-03 | 875 | 77 | 10 | GO:0019904 | |
| GeneOntologyBiologicalProcess | vocal learning | 5.91e-09 | 7 | 76 | 4 | GO:0042297 | |
| GeneOntologyBiologicalProcess | imitative learning | 5.91e-09 | 7 | 76 | 4 | GO:0098596 | |
| GeneOntologyBiologicalProcess | observational learning | 2.11e-08 | 9 | 76 | 4 | GO:0098597 | |
| GeneOntologyBiologicalProcess | learned vocalization behavior or vocal learning | 5.51e-08 | 11 | 76 | 4 | GO:0098598 | |
| GeneOntologyBiologicalProcess | auditory behavior | 1.66e-07 | 14 | 76 | 4 | GO:0031223 | |
| GeneOntologyBiologicalProcess | mechanosensory behavior | 3.91e-07 | 17 | 76 | 4 | GO:0007638 | |
| GeneOntologyBiologicalProcess | vocalization behavior | 1.71e-06 | 24 | 76 | 4 | GO:0071625 | |
| GeneOntologyBiologicalProcess | response to auditory stimulus | 1.02e-05 | 37 | 76 | 4 | GO:0010996 | |
| GeneOntologyBiologicalProcess | neuron cell-cell adhesion | 2.60e-05 | 16 | 76 | 3 | GO:0007158 | |
| GeneOntologyBiologicalProcess | neuroligin clustering involved in postsynaptic membrane assembly | 8.00e-05 | 4 | 76 | 2 | GO:0097118 | |
| GeneOntologyBiologicalProcess | cellular response to Thyroglobulin triiodothyronine | 8.00e-05 | 4 | 76 | 2 | GO:1904017 | |
| GeneOntologyBiologicalProcess | membrane assembly | 9.15e-05 | 64 | 76 | 4 | GO:0071709 | |
| GeneOntologyBiologicalProcess | gephyrin clustering involved in postsynaptic density assembly | 1.33e-04 | 5 | 76 | 2 | GO:0097116 | |
| GeneOntologyBiologicalProcess | membrane biogenesis | 1.53e-04 | 73 | 76 | 4 | GO:0044091 | |
| GeneOntologyBiologicalProcess | social behavior | 1.61e-04 | 74 | 76 | 4 | GO:0035176 | |
| GeneOntologyBiologicalProcess | biological process involved in intraspecies interaction between organisms | 1.79e-04 | 76 | 76 | 4 | GO:0051703 | |
| GeneOntologyBiologicalProcess | response to Thyroglobulin triiodothyronine | 1.99e-04 | 6 | 76 | 2 | GO:1904016 | |
| GeneOntologyBiologicalProcess | postsynaptic density assembly | 2.65e-04 | 34 | 76 | 3 | GO:0097107 | |
| GeneOntologyBiologicalProcess | axon midline choice point recognition | 2.78e-04 | 7 | 76 | 2 | GO:0016199 | |
| GeneOntologyBiologicalProcess | neural plate morphogenesis | 4.74e-04 | 9 | 76 | 2 | GO:0001839 | |
| GeneOntologyBiologicalProcess | axon choice point recognition | 4.74e-04 | 9 | 76 | 2 | GO:0016198 | |
| GeneOntologyBiologicalProcess | postsynaptic specialization assembly | 5.71e-04 | 44 | 76 | 3 | GO:0098698 | |
| GeneOntologyBiologicalProcess | regulation of organelle assembly | 5.85e-04 | 280 | 76 | 6 | GO:1902115 | |
| GeneOntologyBiologicalProcess | ESCRT III complex disassembly | 5.92e-04 | 10 | 76 | 2 | GO:1904903 | |
| GeneOntologyBiologicalProcess | positive regulation of synapse maturation | 5.92e-04 | 10 | 76 | 2 | GO:0090129 | |
| GeneOntologyBiologicalProcess | ESCRT complex disassembly | 5.92e-04 | 10 | 76 | 2 | GO:1904896 | |
| GeneOntologyCellularComponent | Golgi lumen | 4.77e-06 | 109 | 83 | 6 | GO:0005796 | |
| MousePheno | abnormal breathing pattern | 4.82e-05 | 303 | 61 | 8 | MP:0001951 | |
| MousePheno | abnormal response to social novelty | 6.00e-05 | 49 | 61 | 4 | MP:0020395 | |
| MousePheno | abnormal social/conspecific interaction behavior | 8.09e-05 | 421 | 61 | 9 | MP:0002557 | |
| Domain | SEA | 1.18e-11 | 14 | 77 | 6 | SM00200 | |
| Domain | SEA | 3.84e-10 | 23 | 77 | 6 | PS50024 | |
| Domain | SEA_dom | 3.84e-10 | 23 | 77 | 6 | IPR000082 | |
| Domain | SEA | 2.60e-08 | 22 | 77 | 5 | PF01390 | |
| Domain | Neurexin-like | 2.59e-07 | 14 | 77 | 4 | IPR003585 | |
| Domain | 4.1m | 2.59e-07 | 14 | 77 | 4 | SM00294 | |
| Domain | LRRC37AB_C | 2.69e-07 | 4 | 77 | 3 | PF14914 | |
| Domain | LRRC37_N | 2.69e-07 | 4 | 77 | 3 | IPR032754 | |
| Domain | LRRC37AB_C | 2.69e-07 | 4 | 77 | 3 | IPR029423 | |
| Domain | LRRC37 | 2.69e-07 | 4 | 77 | 3 | PF15779 | |
| Domain | LRRC37A/B-like | 2.69e-07 | 4 | 77 | 3 | IPR015753 | |
| Domain | - | 3.52e-07 | 15 | 77 | 4 | 3.30.70.960 | |
| Domain | Syndecan | 2.33e-06 | 7 | 77 | 3 | PF01034 | |
| Domain | Syndecan/Neurexin_dom | 2.33e-06 | 7 | 77 | 3 | IPR027789 | |
| Domain | EGF_3 | 5.56e-06 | 235 | 77 | 8 | PS50026 | |
| Domain | EGF-like_dom | 8.49e-06 | 249 | 77 | 8 | IPR000742 | |
| Domain | EGF_1 | 1.01e-05 | 255 | 77 | 8 | PS00022 | |
| Domain | EGF-like_CS | 1.20e-05 | 261 | 77 | 8 | IPR013032 | |
| Domain | EGF_2 | 1.33e-05 | 265 | 77 | 8 | PS01186 | |
| Domain | - | 4.53e-05 | 95 | 77 | 5 | 2.60.120.200 | |
| Domain | Homeobox_Pitx/unc30 | 5.02e-05 | 3 | 77 | 2 | IPR016233 | |
| Domain | EGF | 5.20e-05 | 235 | 77 | 7 | SM00181 | |
| Domain | LAM_G_DOMAIN | 5.12e-04 | 38 | 77 | 3 | PS50025 | |
| Domain | Laminin_G_2 | 5.96e-04 | 40 | 77 | 3 | PF02210 | |
| Domain | LamG | 7.90e-04 | 44 | 77 | 3 | SM00282 | |
| Domain | Snf7_fam | 1.08e-03 | 12 | 77 | 2 | IPR005024 | |
| Domain | Snf7 | 1.08e-03 | 12 | 77 | 2 | PF03357 | |
| Domain | OAR | 1.70e-03 | 15 | 77 | 2 | PF03826 | |
| Domain | Laminin_G | 1.77e-03 | 58 | 77 | 3 | IPR001791 | |
| Domain | EGF | 1.83e-03 | 126 | 77 | 4 | PF00008 | |
| Domain | OAR | 1.94e-03 | 16 | 77 | 2 | PS50803 | |
| Domain | VWD | 1.94e-03 | 16 | 77 | 2 | SM00216 | |
| Domain | VWF_type-D | 1.94e-03 | 16 | 77 | 2 | IPR001846 | |
| Domain | VWFD | 1.94e-03 | 16 | 77 | 2 | PS51233 | |
| Domain | OAR_dom | 1.94e-03 | 16 | 77 | 2 | IPR003654 | |
| Domain | VWD | 1.94e-03 | 16 | 77 | 2 | PF00094 | |
| Domain | ConA-like_dom | 2.11e-03 | 219 | 77 | 5 | IPR013320 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 4.17e-09 | 16 | 58 | 5 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 5.89e-09 | 17 | 58 | 5 | M27412 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 3.14e-08 | 23 | 58 | 5 | M556 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 6.09e-08 | 26 | 58 | 5 | M27483 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 1.47e-06 | 21 | 58 | 4 | MM15706 | |
| Pathway | WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS | 4.22e-06 | 27 | 58 | 4 | M45550 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 5.35e-06 | 62 | 58 | 5 | M546 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 8.46e-06 | 68 | 58 | 5 | M27303 | |
| Pathway | REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY | 8.51e-06 | 32 | 58 | 4 | M27900 | |
| Pathway | WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV | 9.66e-06 | 33 | 58 | 4 | M39875 | |
| Pathway | WP_RETT_SYNDROME | 4.39e-05 | 48 | 58 | 4 | M39759 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 9.09e-05 | 111 | 58 | 5 | M27416 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 1.06e-04 | 60 | 58 | 4 | MM15636 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2 | 1.28e-04 | 63 | 58 | 4 | M27862 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 2.70e-04 | 140 | 58 | 5 | M27484 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 2.98e-04 | 143 | 58 | 5 | M27275 | |
| Pathway | REACTOME_NEUREXINS_AND_NEUROLIGINS | 3.01e-04 | 32 | 58 | 3 | MM15326 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.04e-03 | 109 | 58 | 4 | MM15164 | |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 5.73e-10 | 18 | 83 | 5 | 18834073 | |
| Pubmed | NCOA2 NCOR1 ARHGAP32 PDE4A ANK2 NRXN1 FOXP2 CAMK2B HECTD4 PRKCI ZNF318 MTCL1 HUWE1 FOXG1 WNK2 TP53BP1 | 9.63e-10 | 963 | 83 | 16 | 28671696 | |
| Pubmed | Endogenous β-neurexins on axons and within synapses show regulated dynamic behavior. | 1.31e-08 | 3 | 83 | 3 | 34133920 | |
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 38891114 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 30858964 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 28013231 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 16406382 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 31812984 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 10512748 | ||
| Pubmed | Structure and evolution of neurexin genes: insight into the mechanism of alternative splicing. | 1.31e-08 | 3 | 83 | 3 | 12036300 | |
| Pubmed | β-Neurexins Control Neural Circuits by Regulating Synaptic Endocannabinoid Signaling. | 1.31e-08 | 3 | 83 | 3 | 26213384 | |
| Pubmed | Neurexin gene family variants as risk factors for autism spectrum disorder. | 1.31e-08 | 3 | 83 | 3 | 29045040 | |
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 31005376 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 38571813 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 35173587 | ||
| Pubmed | Neurexins are differentially expressed in the embryonic nervous system of mice. | 1.31e-08 | 3 | 83 | 3 | 7722633 | |
| Pubmed | Regulated Dynamic Trafficking of Neurexins Inside and Outside of Synaptic Terminals. | 1.31e-08 | 3 | 83 | 3 | 26446217 | |
| Pubmed | Analysis of the human neurexin genes: alternative splicing and the generation of protein diversity. | 1.31e-08 | 3 | 83 | 3 | 11944992 | |
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 33058888 | ||
| Pubmed | Important contribution of alpha-neurexins to Ca2+-triggered exocytosis of secretory granules. | 1.31e-08 | 3 | 83 | 3 | 17035546 | |
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 9448462 | ||
| Pubmed | Deletion of α-neurexin II results in autism-related behaviors in mice. | 1.31e-08 | 3 | 83 | 3 | 25423136 | |
| Pubmed | Postsynaptic N-methyl-D-aspartate receptor function requires alpha-neurexins. | 5.23e-08 | 4 | 83 | 3 | 14983056 | |
| Pubmed | 5.23e-08 | 4 | 83 | 3 | 32706374 | ||
| Pubmed | 5.23e-08 | 4 | 83 | 3 | 8786425 | ||
| Pubmed | 5.23e-08 | 4 | 83 | 3 | 17347997 | ||
| Pubmed | 5.23e-08 | 4 | 83 | 3 | 22419166 | ||
| Pubmed | Neurexins cluster Ca2+ channels within the presynaptic active zone. | 5.23e-08 | 4 | 83 | 3 | 32134527 | |
| Pubmed | 5.23e-08 | 4 | 83 | 3 | 35385735 | ||
| Pubmed | Neurexins regulate presynaptic GABAB-receptors at central synapses. | 5.23e-08 | 4 | 83 | 3 | 33888718 | |
| Pubmed | 1.31e-07 | 5 | 83 | 3 | 28472659 | ||
| Pubmed | 1.31e-07 | 5 | 83 | 3 | 36709330 | ||
| Pubmed | 1.31e-07 | 5 | 83 | 3 | 20537373 | ||
| Pubmed | Neuroligins and neurexins link synaptic function to cognitive disease. | 1.31e-07 | 5 | 83 | 3 | 18923512 | |
| Pubmed | 1.31e-07 | 5 | 83 | 3 | 9223334 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.67e-07 | 351 | 83 | 9 | 38297188 | |
| Pubmed | 2.05e-07 | 105 | 83 | 6 | 9628581 | ||
| Pubmed | Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis. | 2.61e-07 | 6 | 83 | 3 | 12827191 | |
| Pubmed | Structures, alternative splicing, and neurexin binding of multiple neuroligins. | 2.61e-07 | 6 | 83 | 3 | 8576240 | |
| Pubmed | 2.61e-07 | 6 | 83 | 3 | 30683685 | ||
| Pubmed | Neuroligin-1 Signaling Controls LTP and NMDA Receptors by Distinct Molecular Pathways. | 7.28e-07 | 8 | 83 | 3 | 30871858 | |
| Pubmed | 7.28e-07 | 8 | 83 | 3 | 37591863 | ||
| Pubmed | NCOA2 NCOR1 ALMS1 ZNF318 HUWE1 LRBA PRPF40A HCFC1 TP53BP1 HTT | 7.67e-07 | 549 | 83 | 10 | 38280479 | |
| Pubmed | 1.09e-06 | 9 | 83 | 3 | 34919427 | ||
| Pubmed | 1.09e-06 | 9 | 83 | 3 | 9707552 | ||
| Pubmed | 1.55e-06 | 10 | 83 | 3 | 23064749 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PCNX2 NCOR1 TEAD2 PDE4A HIVEP2 MCM3AP PITX1 HECTD4 HUWE1 LRBA HCFC1 WNK2 HTT | 2.11e-06 | 1105 | 83 | 13 | 35748872 |
| Pubmed | 2.13e-06 | 11 | 83 | 3 | 32973045 | ||
| Pubmed | 4.53e-06 | 101 | 83 | 5 | 9872452 | ||
| Pubmed | The contribution of rare and common variants in 30 genes to risk nicotine dependence. | 4.68e-06 | 14 | 83 | 3 | 25450229 | |
| Pubmed | Enhancer interaction networks as a means for singular olfactory receptor expression. | 4.68e-06 | 14 | 83 | 3 | 25417106 | |
| Pubmed | Floor-plate-derived netrin-1 is dispensable for commissural axon guidance. | 4.68e-06 | 14 | 83 | 3 | 28445456 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 37178987 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 12958310 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 37543682 | ||
| Pubmed | Neurexin I alpha is a major alpha-latrotoxin receptor that cooperates in alpha-latrotoxin action. | 5.63e-06 | 2 | 83 | 2 | 9430716 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 9026314 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 30709877 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 21566141 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 12858527 | ||
| Pubmed | Multiple transcripts of MUC3: evidence for two genes, MUC3A and MUC3B. | 5.63e-06 | 2 | 83 | 2 | 10973822 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 19658047 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 9334251 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 19208825 | ||
| Pubmed | Molecular cloning of cDNAs derived from a novel human intestinal mucin gene. | 5.63e-06 | 2 | 83 | 2 | 2393399 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 36029989 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 11289722 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 23544943 | ||
| Pubmed | Neurexins: synaptic cell surface proteins related to the alpha-latrotoxin receptor and laminin. | 5.63e-06 | 2 | 83 | 2 | 1621094 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 26595880 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 14690056 | ||
| Pubmed | Increased Levels of Rictor Prevent Mutant Huntingtin-Induced Neuronal Degeneration. | 5.63e-06 | 2 | 83 | 2 | 29460266 | |
| Pubmed | The MUC3 gene encodes a transmembrane mucin and is alternatively spliced. | 5.63e-06 | 2 | 83 | 2 | 10405327 | |
| Pubmed | Expression of the members of the Ptx family of transcription factors in human pituitary adenomas. | 5.63e-06 | 2 | 83 | 2 | 10372733 | |
| Pubmed | Huntingtin: an iron-regulated protein essential for normal nuclear and perinuclear organelles. | 5.84e-06 | 15 | 83 | 3 | 11092755 | |
| Pubmed | SOX6 NCOA2 NCOR1 SP2 ARHGAP32 TEAD2 ALMS1 FOXP2 PITX1 ZNF318 PRPF40A HCFC1 LRIF1 TP53BP1 | 6.82e-06 | 1429 | 83 | 14 | 35140242 | |
| Pubmed | 1.08e-05 | 57 | 83 | 4 | 21122108 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 1.15e-05 | 588 | 83 | 9 | 38580884 | |
| Pubmed | 1.55e-05 | 130 | 83 | 5 | 12421765 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 18339718 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 9922405 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 12149646 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 23053434 | ||
| Pubmed | Thyroid hormone signaling in vivo requires a balance between coactivators and corepressors. | 1.69e-05 | 3 | 83 | 2 | 24550004 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 16391387 | ||
| Pubmed | Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia. | 1.69e-05 | 3 | 83 | 2 | 21424692 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 27230679 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 30236127 | ||
| Pubmed | Expression of mucin 3 and mucin 5AC in arthritic synovial tissue. | 1.69e-05 | 3 | 83 | 2 | 18163520 | |
| Pubmed | CHMP1 is a novel nuclear matrix protein affecting chromatin structure and cell-cycle progression. | 1.69e-05 | 3 | 83 | 2 | 11559747 | |
| Pubmed | Regulation of membrane-associated mucins in the human corneal epithelial cells by dexamethasone. | 1.69e-05 | 3 | 83 | 2 | 17592322 | |
| Pubmed | PITX2 AND PITX1 regulate thyrotroph function and response to hypothyroidism. | 1.69e-05 | 3 | 83 | 2 | 21964592 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 20065027 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 12799135 | ||
| Pubmed | Language development and disorders: Possible genes and environment interactions. | 1.69e-05 | 3 | 83 | 2 | 30077386 | |
| Pubmed | Pitx factors are involved in basal and hormone-regulated activity of the human prolactin promoter. | 1.69e-05 | 3 | 83 | 2 | 12223489 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 35879412 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 27483328 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 24204560 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 24939955 | ||
| Interaction | YWHAH interactions | NCOA2 ARHGAP32 HIVEP2 ALMS1 SHCBP1 HECTD4 PACS2 RICTOR PRKCI CBARP MTCL1 HUWE1 LRBA TMCC1 WNK2 HTT | 3.34e-06 | 1102 | 77 | 16 | int:YWHAH |
| Interaction | WWTR1 interactions | NCOA2 NCOR1 TEAD2 ALMS1 ZNF318 LRBA PRPF40A HCFC1 TP53BP1 HTT | 4.57e-06 | 422 | 77 | 10 | int:WWTR1 |
| Interaction | YWHAZ interactions | NCOR1 ARHGAP32 LNX2 HIVEP2 NRXN1 CAMK2B SHCBP1 HECTD4 PACS2 RICTOR PRKCI CBARP HUWE1 TMCC1 WNK2 TP53BP1 HTT | 7.69e-06 | 1319 | 77 | 17 | int:YWHAZ |
| Interaction | YWHAG interactions | ARHGAP32 LNX2 HIVEP2 ALMS1 SHCBP1 HECTD4 PACS2 RICTOR PRKCI CBARP MTCL1 HUWE1 LRBA PRPF40A TMCC1 HTT | 1.60e-05 | 1248 | 77 | 16 | int:YWHAG |
| Interaction | CCNT1 interactions | 2.44e-05 | 225 | 77 | 7 | int:CCNT1 | |
| Interaction | C6orf141 interactions | 2.71e-05 | 92 | 77 | 5 | int:C6orf141 | |
| Interaction | NR2F1 interactions | 7.15e-05 | 58 | 77 | 4 | int:NR2F1 | |
| Interaction | NLGN1 interactions | 7.84e-05 | 22 | 77 | 3 | int:NLGN1 | |
| Interaction | SATB1 interactions | 8.23e-05 | 116 | 77 | 5 | int:SATB1 | |
| Interaction | B4GALT2 interactions | 9.28e-05 | 119 | 77 | 5 | int:B4GALT2 | |
| GeneFamily | CD molecules|Mucins | 1.39e-13 | 21 | 53 | 7 | 648 | |
| GeneFamily | Charged multivesicular body proteins|ESCRT-III associated factors | 8.38e-05 | 5 | 53 | 2 | 1119 | |
| GeneFamily | Charged multivesicular body proteins|ESCRT-III associated factors | 4.56e-04 | 11 | 53 | 2 | 482 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA | NRXN3 SEMA6D ANK2 NRXN1 FOXP2 NRXN2 CAMK2B RTL9 MUC16 ROBO1 ZNF568 | 3.93e-07 | 506 | 80 | 11 | M39067 |
| Coexpression | NABA_ECM_AFFILIATED | 9.10e-07 | 170 | 80 | 7 | M5880 | |
| Coexpression | GSE25846_IL10_POS_VS_NEG_CD8_TCELL_DAY7_POST_CORONAVIRUS_BRAIN_UP | 2.99e-05 | 195 | 80 | 6 | M8140 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#2_top-relative-expression-ranked_500 | 1.06e-05 | 132 | 80 | 6 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k2_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.37e-05 | 138 | 80 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | SOX6 NCOA2 LNX2 NRXN3 ANK2 ALMS1 NRXN2 GYPC LRBA TMEM123 PRPF40A FOXG1 WNK2 | 7.32e-05 | 983 | 80 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.49e-09 | 179 | 82 | 8 | 859cd8ee414ad6207c046ada2e655e49322dd01c | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.55e-09 | 180 | 82 | 8 | 3dc80bc636bf0e6ffc9762853132a9fe59fd1f66 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.55e-09 | 180 | 82 | 8 | 668a2d8e1d5a390309d5eb62c836f5903144bea9 | |
| ToppCell | Control-Epithelial_cells-Airway_goblet|Control / group, cell type (main and fine annotations) | 1.85e-09 | 184 | 82 | 8 | d92a71441e4e19f8c301999d8186f8e48e3cd162 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.19e-08 | 194 | 82 | 7 | e0228f593c3493175962a4817500d4337ddc4e88 | |
| ToppCell | proximal-3-Epithelial-Goblet|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.27e-08 | 198 | 82 | 7 | 3477202c4f702d8f75231b13d4b5216f56d981d7 | |
| ToppCell | proximal-Epithelial-Goblet|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.27e-08 | 198 | 82 | 7 | e7e1c430486a81280abc4a7e7f5bc3713dd20737 | |
| ToppCell | proximal-Epithelial-Goblet-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.27e-08 | 198 | 82 | 7 | da7b40eb00bb5e454e1cfcd1219dc0d84712592a | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.35e-07 | 161 | 82 | 6 | 2d63b279d9a5132e1c09b03930bf9039036d24a2 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.14e-07 | 173 | 82 | 6 | 464267a2ff3f5c387b6c9c6fa4dab135a221f448 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_goblet_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.31e-07 | 177 | 82 | 6 | a4c001a8e44142babf9f24dfe6f7b73a70b11b16 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Secretory/RAS|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.31e-07 | 177 | 82 | 6 | 779ba86f53650772755b52460be03f18bb204e55 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Secretory/RAS-Secretory|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.31e-07 | 177 | 82 | 6 | 0f210cfb61b873c5fd77dc17eadf4d017306500e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_goblet_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.31e-07 | 177 | 82 | 6 | 363e07b0f347f3716d530a28ead854b98e27d37c | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.94e-07 | 179 | 82 | 6 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 1.13e-06 | 183 | 82 | 6 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 1.41e-06 | 190 | 82 | 6 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-06 | 193 | 82 | 6 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-06 | 193 | 82 | 6 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-06 | 193 | 82 | 6 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.63e-06 | 195 | 82 | 6 | e7230a849ea31e6eef9bc6f5468938499450582d | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.79e-06 | 198 | 82 | 6 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.79e-06 | 198 | 82 | 6 | 5dd2aa7684c36beffa204ca4c04d0501cabac10f | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.79e-06 | 198 | 82 | 6 | fab3135f03cf23a9f04f0eed543a9dc181f39f5f | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.84e-06 | 199 | 82 | 6 | 3c3133d0aa65338a576634def13e7f0f5c573a10 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.84e-06 | 199 | 82 | 6 | a706ad5cd5e0dc8d7e925a05e45b07d35963f294 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-MUC5AC+_High|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.84e-06 | 199 | 82 | 6 | a5240868cea40574ed4ee45eb27a00c1812957ed | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Duct|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.89e-06 | 200 | 82 | 6 | b992eeddee38e6fe3564e9b1850f6b20b89bf47d | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 1.89e-06 | 200 | 82 | 6 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | metastatic_Brain-T/NK_cells-Cytotoxic_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 1.20e-05 | 161 | 82 | 5 | e6e294b4ba911c1327664f1a0f93207096c6de03 | |
| ToppCell | 5'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell-SMG_duct|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.28e-05 | 163 | 82 | 5 | a1fbefe53523a9879a4d4b493071059798b5f917 | |
| ToppCell | 5'-Airway_Nasal_SMG-Epithelial|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.28e-05 | 163 | 82 | 5 | 454a5e87e2f9f66e38cc5aa1b433c47b54c9be42 | |
| ToppCell | 5'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.28e-05 | 163 | 82 | 5 | d9bd9d90cfa4e85d5ea51f8f3ee14a700571f508 | |
| ToppCell | 5'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.28e-05 | 163 | 82 | 5 | f6847f47a8856c0d4136c1af317432d45eccfde9 | |
| ToppCell | 5'-Airway_Nasal_SMG|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.28e-05 | 163 | 82 | 5 | d8450bf9c6d2ec5dd1472952c9e65f82f995337a | |
| ToppCell | 5'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell-SMG_duct-SMG_duct_L.0.6.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.28e-05 | 163 | 82 | 5 | be6cc44df9a2b10dce1a353717c279c3558f8fec | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.32e-05 | 164 | 82 | 5 | 6e6aedb61f8e195d52e028fdda750a29bb14e57e | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.36e-05 | 165 | 82 | 5 | 9795ce31689bc63f5a2d68725ef00b23a90c3846 | |
| ToppCell | COVID-19-Heart-Neuronal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.48e-05 | 168 | 82 | 5 | 88c2c574f428c2502b5fe099bd73b0758f668ef6 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ionocyte|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.48e-05 | 168 | 82 | 5 | 6a233045638cb83dab64789b996b7598c325001e | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.75e-05 | 174 | 82 | 5 | 7d2f802f493f19a068e097b2909a9000e2160266 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Proximal_secretory_3|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.85e-05 | 176 | 82 | 5 | 8d9d0fb46c418b2067be58aec822e8c2b1561461 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell|Adult / Lineage, Cell type, age group and donor | 2.01e-05 | 179 | 82 | 5 | 1fc1f252ca943a2f649d1e627f56acbf15f8e058 | |
| ToppCell | droplet-Large_Intestine-COLON_-_"PROM_Tm"-30m-Hematologic-hematopoietic_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-05 | 179 | 82 | 5 | cb880ef40c203c8bd16c4f69a70cf59f97ebbffd | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-05 | 179 | 82 | 5 | a3922476f33d2e4137a12dbda21a1703dff79684 | |
| ToppCell | droplet-Large_Intestine-COLON_-_"PROM_Tm"-30m-Hematologic|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-05 | 179 | 82 | 5 | 686b9f745d290ca686b42d9505e9792c78667e6e | |
| ToppCell | droplet-Large_Intestine-COLON_-_"PROM_Tm"-30m-Hematologic-hematopoietic_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-05 | 179 | 82 | 5 | 1eb004e1a17e1f1e4337e0581e547c0f5a965e68 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.06e-05 | 180 | 82 | 5 | 6b1606238417490e0d9930870a7827419d1c3737 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Basal/Club|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.12e-05 | 181 | 82 | 5 | faff2a34e391d053a17c926540e6cb46d94dd629 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Basal/Club-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.12e-05 | 181 | 82 | 5 | 5a9c332c0bf07cc20eaf8cf77b45e73668a6467d | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Basal/Club-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.12e-05 | 181 | 82 | 5 | 488a517f6e5543b648a2e72e0e04332fad776de6 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Basal/Club|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.12e-05 | 181 | 82 | 5 | 58651853f9c715075889856793df66ebe00c04f1 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.17e-05 | 182 | 82 | 5 | 3f1a666fe27dd7529c114539ed5f6b8ca585c875 | |
| ToppCell | Epithelial-lung_goblet_cell|World / Lineage, Cell type, age group and donor | 2.23e-05 | 183 | 82 | 5 | 940cbe298e9c53b5622af09264586ed823d3141f | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.35e-05 | 185 | 82 | 5 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | COPD-Epithelial-Goblet|World / Disease state, Lineage and Cell class | 2.41e-05 | 186 | 82 | 5 | d75fe7640a4b2c450c9759a1b3c3ef2a087f0092 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.54e-05 | 188 | 82 | 5 | 5901b276f2379abf486b8285957277e95f08464e | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 2.60e-05 | 189 | 82 | 5 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.67e-05 | 190 | 82 | 5 | 6ea9fa08bd97bedcb21d3654467e7f8dd74c8fd0 | |
| ToppCell | Globus_pallidus-Neuronal|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.67e-05 | 190 | 82 | 5 | 416de85d8841dac883faa6f5339b2fb461a09e82 | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-SMG_Basal/Duct|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.74e-05 | 191 | 82 | 5 | 30e7cc5f7eadf90ab0900a73fdfe48f9a1adcbfb | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-SMG_Basal/Duct-SMG_Basal/Duct|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.74e-05 | 191 | 82 | 5 | 41d2f5278f6d5f52a5bdf4f3df70969481c00162 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 2.81e-05 | 192 | 82 | 5 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| ToppCell | COPD-Epithelial-Goblet|COPD / Disease state, Lineage and Cell class | 2.81e-05 | 192 | 82 | 5 | 93b2ca0a97776d28c7e8f1a0642c4b63a5554aab | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-Goblet|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.88e-05 | 193 | 82 | 5 | 71bf8fb5314b79cb30f4eb9c8459b21f10cd6d35 | |
| ToppCell | 21-Trachea-Epithelial-Epithelial|Trachea / Age, Tissue, Lineage and Cell class | 2.88e-05 | 193 | 82 | 5 | 9a8bb44a37f3202e3123a6680bd5545dc91a6d40 | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.88e-05 | 193 | 82 | 5 | b05e110b13d35d34294357c8e1c4fd23bf4b6c92 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.95e-05 | 194 | 82 | 5 | 68d15917ae222cba0ad9e716d29eebb6c5f00f69 | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.95e-05 | 194 | 82 | 5 | d0fb1ff5cf0738881e114a58f0b27489f781d72b | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_submucosal-gland-SMG_Duct|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.02e-05 | 195 | 82 | 5 | fc2a1d84b3d013e5cb9e7b9cdd740e4010897d20 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.02e-05 | 195 | 82 | 5 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 | |
| ToppCell | 15-Trachea-Epithelial-Epithelial|Trachea / Age, Tissue, Lineage and Cell class | 3.02e-05 | 195 | 82 | 5 | 9e9283a397f56732a0a5f2e2527f154d4c2dd56a | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 3.10e-05 | 196 | 82 | 5 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.10e-05 | 196 | 82 | 5 | c18874f37b90e6afacc562b2082b67ea8a7cb4a4 | |
| ToppCell | COVID-19-Epithelial-Club,_Basal_cells|COVID-19 / Condition, Lineage and Cell class | 3.10e-05 | 196 | 82 | 5 | dd32046067d93b9484cfbf1d7826a436a3d9f0e9 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.10e-05 | 196 | 82 | 5 | a52879a4c822c5e4be569f01f845a795e00c5f4b | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Basal/Club-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.10e-05 | 196 | 82 | 5 | a4d05d85fbafa869df19bba3881020ea433d81fb | |
| ToppCell | Bronchial-NucSeq-Stromal-Schwann|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.10e-05 | 196 | 82 | 5 | a90c76d9c57a4491b94a321ba541b792ec5d8e83 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Basal/Club-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.10e-05 | 196 | 82 | 5 | 91a3c3091064f1f5a3bdc1dd5883fc24dce8ff05 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Basal/Club|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.10e-05 | 196 | 82 | 5 | e819088a74d29e958371aa851ac9c74ec55367b7 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Basal/Club|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.10e-05 | 196 | 82 | 5 | e675d661b6494ac3a85ba7ee5bdeaa98b8bbe957 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.10e-05 | 196 | 82 | 5 | 7a4d502550e9e37dc42f2ff1be3c896afe365d7f | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.10e-05 | 196 | 82 | 5 | 60ea673ed887fe3890c5cf4ff4165384b76d7361 | |
| ToppCell | distal-Epithelial-Goblet|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.18e-05 | 197 | 82 | 5 | da1ed7303cc9cb2d205c0e5c49c52544d3540951 | |
| ToppCell | AT2_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 3.18e-05 | 197 | 82 | 5 | 5e0d222872a25bb9e9069d3dffda2844bb69874a | |
| ToppCell | distal-3-Epithelial-Goblet|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.18e-05 | 197 | 82 | 5 | a00784ccfb1de6a96b91e2a8a2889b69f31a33da | |
| ToppCell | Bronchial-NucSeq-Stromal-Schwann-Schwann_nonmyelinating|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.18e-05 | 197 | 82 | 5 | 4a7ff67bb0754e034e6f2a1bd34cde86ee3ef899 | |
| ToppCell | Bronchus_Control_(B.)|World / Sample group, Lineage and Cell type | 3.18e-05 | 197 | 82 | 5 | b6dff2ee108813e18657e2d8cf850e2423f8c8e9 | |
| ToppCell | Mild_COVID-19-Epithelial-Basal/Club|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 3.18e-05 | 197 | 82 | 5 | 4cc5b778e1e2c6c149160fa147c172977c0fa8eb | |
| ToppCell | distal-Epithelial-Goblet-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.18e-05 | 197 | 82 | 5 | 3fbf456ae4f73da4f6254a6f0d24f0ec27d7a3cc | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_basal-Suprabasal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.25e-05 | 198 | 82 | 5 | de5987588b9fa9ee8c595ba06d7d844ead0e3c74 | |
| ToppCell | NS-critical-d_07-13|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.25e-05 | 198 | 82 | 5 | a6e11c87b31beffb6af190c64b4ef3ee1d9dab8d | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M|organoid_Kanton_Nature / Sample Type, Dataset, Time_group, and Cell type. | 3.33e-05 | 199 | 82 | 5 | b2d7dea11207cca63d688f8051143850b29dbdf0 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.33e-05 | 199 | 82 | 5 | ec1e110671e7725f752163c7241dbbf638dec2b2 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 3.33e-05 | 199 | 82 | 5 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Striatum-Neuronal|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.41e-05 | 200 | 82 | 5 | c888fd487990cad482a4ca47601cdebc0ca3f3ce | |
| ToppCell | Tracheal|World / Cell types per location group and 10X technology with lineage, and cell group designations | 3.41e-05 | 200 | 82 | 5 | 682960e28542a3d6c119047cd0131941932cfdea | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Club|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 3.41e-05 | 200 | 82 | 5 | 292c63693eb7f435335a8cfba07aa35b72139393 | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.41e-05 | 200 | 82 | 5 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Differentiating_Ciliated|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 3.41e-05 | 200 | 82 | 5 | a552a99f5e4fa00dfb7775e5a3e1f62f1530d104 | |
| Drug | Clozapine [5786-21-0]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 5.69e-06 | 195 | 80 | 7 | 5265_UP | |
| Drug | Phenethicillin potassium salt [132-93-4]; Up 200; 10uM; PC3; HT_HG-U133A | 6.28e-06 | 198 | 80 | 7 | 5763_UP | |
| Drug | cellobiitol | 8.54e-06 | 37 | 80 | 4 | CID000003871 | |
| Disease | Autistic Disorder | 4.18e-07 | 261 | 77 | 8 | C0004352 | |
| Disease | cholangiocarcinoma (is_marker_for) | 2.42e-05 | 64 | 77 | 4 | DOID:4947 (is_marker_for) | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 4.98e-05 | 152 | 77 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 5.80e-05 | 157 | 77 | 5 | DOID:224 (biomarker_via_orthology) | |
| Disease | polycystic ovary syndrome (implicated_via_orthology) | 1.00e-04 | 6 | 77 | 2 | DOID:11612 (implicated_via_orthology) | |
| Disease | age at diagnosis, substance-related disorder | 1.00e-04 | 6 | 77 | 2 | EFO_0004918, MONDO_0002494 | |
| Disease | Intellectual Disability | 1.69e-04 | 447 | 77 | 7 | C3714756 | |
| Disease | underweight body mass index status | 2.39e-04 | 9 | 77 | 2 | EFO_0005936 | |
| Disease | otitis media (is_marker_for) | 2.98e-04 | 10 | 77 | 2 | DOID:10754 (is_marker_for) | |
| Disease | cognitive inhibition measurement | 3.07e-04 | 50 | 77 | 3 | EFO_0007969 | |
| Disease | polymyositis (is_marker_for) | 3.64e-04 | 11 | 77 | 2 | DOID:0080745 (is_marker_for) | |
| Disease | Semantic-Pragmatic Disorder | 3.64e-04 | 11 | 77 | 2 | C0454655 | |
| Disease | Auditory Processing Disorder, Central | 3.64e-04 | 11 | 77 | 2 | C0751257 | |
| Disease | Language Delay | 3.64e-04 | 11 | 77 | 2 | C0023012 | |
| Disease | Language Development Disorders | 3.64e-04 | 11 | 77 | 2 | C0023014 | |
| Disease | Speech Delay | 3.64e-04 | 11 | 77 | 2 | C0241210 | |
| Disease | outer ear morphology trait | 4.36e-04 | 12 | 77 | 2 | EFO_0007664 | |
| Disease | Alzheimer's disease (implicated_via_orthology) | 4.52e-04 | 57 | 77 | 3 | DOID:10652 (implicated_via_orthology) | |
| Disease | systolic blood pressure, cigarettes per day measurement | 5.15e-04 | 13 | 77 | 2 | EFO_0006335, EFO_0006525 | |
| Disease | Mental Depression | 5.42e-04 | 254 | 77 | 5 | C0011570 | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 5.51e-04 | 61 | 77 | 3 | DOID:3587 (is_marker_for) | |
| Disease | sulfate measurement | 5.99e-04 | 14 | 77 | 2 | EFO_0007864 | |
| Disease | Ischemic stroke, tissue plasminogen activator measurement | 6.90e-04 | 15 | 77 | 2 | EFO_0004791, HP_0002140 | |
| Disease | Ischemic stroke, plasminogen activator inhibitor 1 measurement | 7.88e-04 | 16 | 77 | 2 | EFO_0004792, HP_0002140 | |
| Disease | 1-Methylhistidine measurement | 8.91e-04 | 17 | 77 | 2 | EFO_0021543 | |
| Disease | factor XI measurement, Ischemic stroke | 8.91e-04 | 17 | 77 | 2 | EFO_0004694, HP_0002140 | |
| Disease | Depressive disorder | 9.68e-04 | 289 | 77 | 5 | C0011581 | |
| Disease | attention deficit hyperactivity disorder, Cannabis use | 1.00e-03 | 18 | 77 | 2 | EFO_0003888, EFO_0007585 | |
| Disease | factor VIII measurement, Ischemic stroke | 1.12e-03 | 19 | 77 | 2 | EFO_0004630, HP_0002140 | |
| Disease | post-traumatic stress disorder symptom measurement | 1.30e-03 | 82 | 77 | 3 | EFO_0008535 | |
| Disease | hair color | 1.34e-03 | 311 | 77 | 5 | EFO_0003924 | |
| Disease | Autism Spectrum Disorders | 1.45e-03 | 85 | 77 | 3 | C1510586 | |
| Disease | smoking cessation | 1.62e-03 | 325 | 77 | 5 | EFO_0004319 | |
| Disease | frailty measurement | 1.64e-03 | 23 | 77 | 2 | EFO_0009885 | |
| Disease | reaction time measurement | 1.66e-03 | 658 | 77 | 7 | EFO_0008393 | |
| Disease | Malignant neoplasm of breast | 1.90e-03 | 1074 | 77 | 9 | C0006142 | |
| Disease | chronotype measurement | 2.11e-03 | 882 | 77 | 8 | EFO_0008328 | |
| Disease | Schizophrenia | 2.12e-03 | 883 | 77 | 8 | C0036341 | |
| Disease | caudate volume change measurement, age at assessment | 2.26e-03 | 27 | 77 | 2 | EFO_0008007, EFO_0021491 | |
| Disease | colorectal adenocarcinoma (is_marker_for) | 2.26e-03 | 27 | 77 | 2 | DOID:0050861 (is_marker_for) | |
| Disease | Disorder of eye | 2.33e-03 | 212 | 77 | 4 | C0015397 | |
| Disease | 1,5 anhydroglucitol measurement | 2.61e-03 | 29 | 77 | 2 | EFO_0008009 | |
| Disease | Ischemic stroke, factor VII measurement | 2.61e-03 | 29 | 77 | 2 | EFO_0004619, HP_0002140 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MLEQKQSSSSPSMTT | 716 | Q8N944 | |
| MQPTATMATAATTTT | 1 | Q8N350 | |
| TPRTTMTMQTSTLDV | 1596 | Q8IZF6 | |
| MRSHTITMTTTSVSS | 1 | Q9UPC5 | |
| PMMTVIKSDSSSDAS | 2406 | Q8TCU4 | |
| IAGLMSMSTSTTSAV | 296 | O60563 | |
| TWTVPAQTTTPMSTM | 4761 | Q9HC84 | |
| AQTTTPMSTMSTIHT | 4766 | Q9HC84 | |
| TTMATMPTATASTVP | 4881 | Q9HC84 | |
| LTTSVTMTTDTMTSP | 1476 | Q9Y4B5 | |
| MQSDSVSSSFEPTMS | 3006 | Q01484 | |
| TSVMEDSMSSATTLT | 126 | Q9HD42 | |
| QMEDTMSSTTTLTTP | 131 | Q7LBR1 | |
| ENSMSVPSSTSTMKT | 531 | Q9NRJ5 | |
| TSATSTTMTVMATGA | 1171 | P51610 | |
| VMVSKFTSPATSSME | 996 | Q8WXI7 | |
| FTMAKESVSMSVSPS | 1071 | Q8WXI7 | |
| ESVSMSVSPSQSMDA | 1076 | Q8WXI7 | |
| PMTISTHMTTTQTGS | 4671 | Q8WXI7 | |
| ETSSVSSLMSSPAMT | 5331 | Q8WXI7 | |
| SMMEDAIVSTSTPGS | 6046 | Q8WXI7 | |
| PMDTTSTMGHTTVST | 6916 | Q8WXI7 | |
| STMGHTTVSTSMSVS | 6921 | Q8WXI7 | |
| TMTESAEMTIPTQTG | 7021 | Q8WXI7 | |
| FSTSPVMTESAEITM | 7891 | Q8WXI7 | |
| SKVTSPMVITSTMED | 8081 | Q8WXI7 | |
| PMVITSTMEDTSVST | 8086 | Q8WXI7 | |
| PAQSTMSSDTSMETI | 9336 | Q8WXI7 | |
| TSSSIRDNMVSTTMP | 9551 | Q8WXI7 | |
| VPTSATTEVSMTEIM | 9901 | Q8WXI7 | |
| DTLTQMMTSTLFSSP | 91 | Q99102 | |
| TSFPSSVTNTLMMTS | 121 | Q99102 | |
| PSSMTTESTATAMQS | 296 | P58400 | |
| TESTATAMQSEMSTS | 301 | P58400 | |
| TAMQSEMSTSIMETT | 306 | P58400 | |
| SMTEVEPSTALMTTA | 676 | O60309 | |
| MPTQRDSSTMSHTVA | 1 | P41743 | |
| TAMASASPSVMSTNF | 626 | Q8TD91 | |
| SMTEVEPSTALMTTA | 676 | A6NM11 | |
| SMTEVEPSTALMTTA | 676 | A6NMS7 | |
| STSGMVEASQMPTVI | 216 | Q5T3J3 | |
| VPSTFMTMETSHAIT | 201 | O60721 | |
| MTTSFSESTNAMNTT | 2201 | Q2M2H8 | |
| SESTNAMNTTVIMAT | 2206 | Q2M2H8 | |
| AMNTTVIMATTSPTS | 2211 | Q2M2H8 | |
| VKLSTMMSPTTSTNA | 226 | P16150 | |
| SITGSETTMASTMAS | 41 | E2RYF6 | |
| ETTMASTMASTSALT | 46 | E2RYF6 | |
| TMASSIISETTMAST | 166 | E2RYF6 | |
| TTMVSAMGSETTTNS | 366 | E2RYF6 | |
| TMASTMGSETTMAST | 546 | E2RYF6 | |
| TASTTSSETTMASIM | 1016 | E2RYF6 | |
| SSETTMASIMGSETT | 1021 | E2RYF6 | |
| TSVTTSPQSDMMREQ | 1921 | O60318 | |
| MGTTSDEMVSVEQTS | 1 | Q8N448 | |
| VPHPSMTSQSSTSMS | 421 | P55316 | |
| IVITMSSTPNSMTDL | 376 | A6NKB5 | |
| MTETSLSSQCFPMSV | 1 | Q8NH61 | |
| TDVSLSMSTLPSMLS | 71 | Q8NH63 | |
| MTTTEKGTSAMTSSP | 176 | Q02505 | |
| GTMVTSTTMTPSSLS | 426 | Q02505 | |
| PTTDMSTESLTTAMT | 616 | Q02505 | |
| VPTTLGTMVTSTSMI | 796 | Q02505 | |
| GTMVTSTSMISSTVS | 801 | Q02505 | |
| SPTTTTSFTTSTMME | 946 | Q02505 | |
| TSFTTSTMMEPPSST | 951 | Q02505 | |
| SSSITPTNTMTSMRT | 1011 | Q02505 | |
| TSGTMVTSTTMTPSS | 1176 | Q02505 | |
| PITSSITPTDTMTSM | 1386 | Q02505 | |
| ITPTDTMTSMRTTTS | 1391 | Q02505 | |
| TMTSMRTTTSWPTAT | 1396 | Q02505 | |
| TTLGTMVTSTSMIPS | 1551 | Q02505 | |
| MVTSTSMIPSTVSTG | 1556 | Q02505 | |
| NTETSIFVSMMSATT | 1621 | Q02505 | |
| TTTMSFTTFTKMETP | 1701 | Q02505 | |
| TSSMMPESESSISPN | 2831 | Q02505 | |
| MSPKTMSRNSSVTSE | 156 | P27815 | |
| VSSVTMSKNMLETSP | 426 | O15409 | |
| MATTIMETTTTMATT | 1361 | Q9P2S2 | |
| GTTQTTSMPPEMSTT | 1271 | Q9Y4C0 | |
| EMSTTVMETTTTMAT | 1281 | Q9Y4C0 | |
| TMTASGSSAMSPETT | 1181 | P50851 | |
| HSVASMMAVNSSSPT | 136 | Q7L4E1 | |
| PSSMTTESTATAMQS | 1301 | Q9ULB1 | |
| TESTATAMQSEMSTS | 1306 | Q9ULB1 | |
| TAMQSEMSTSIMETT | 1311 | Q9ULB1 | |
| SGEAAATPTMSMTVV | 791 | Q86VP3 | |
| SMEVSTSSSLTPAMS | 3046 | Q9Y4D8 | |
| SPEENTSTATMTYMT | 1251 | A7KAX9 | |
| QLPSMSMLTSKTSTQ | 3706 | Q7Z6Z7 | |
| TTMDTDCGSMSTVVS | 1246 | Q6R327 | |
| TVDDLISDSSSMMSP | 121 | D6RGH6 | |
| TTEIPTTMSTMAAAE | 261 | O75400 | |
| MVSNPCMTSATIDVT | 731 | Q9H158 | |
| NTTTPGMVSTNMTST | 96 | Q8N131 | |
| GMVSTNMTSTTLKST | 101 | Q8N131 | |
| MFVTPNTMASVSTVQ | 1656 | P42858 | |
| GMASASTTMHTTTIA | 21 | P04921 | |
| STVTATTATTTLMMT | 81 | Q9BYW3 | |
| TTATTTLMMTTASMS | 86 | Q9BYW3 | |
| SDTSSSQMVVMTETL | 191 | Q8NGR5 | |
| CSDTSSSQMVVMTET | 226 | Q8NGR2 | |
| ASTMPVATSEMSTLS | 341 | Q685J3 | |
| MSVSTMPVASSEAST | 516 | Q685J3 | |
| RMPVSTTMVASSETS | 1046 | Q685J3 | |
| SMSVSTMPVASSEAS | 2991 | Q685J3 | |
| SSPATLQVTTMRMST | 3556 | Q685J3 | |
| MRMSTPSEGSSSLTT | 3566 | Q685J3 | |
| ATLDSTTMSVSMPME | 3736 | Q685J3 | |
| TTLEGTTTMPMSTTS | 3796 | Q685J3 | |
| TTTMPMSTTSERSTL | 3801 | Q685J3 | |
| MTTTEKGTSAMISSP | 176 | Q9H195 | |
| MVTCPSSISMQTTLA | 726 | Q9H195 | |
| QTTLATHMDTSSMTP | 736 | Q9H195 | |
| THMDTSSMTPESESS | 741 | Q9H195 | |
| TSTQLMTSPVFDTMS | 61 | Q8NET4 | |
| VVCTPIMSTSSSEAM | 176 | Q8NET4 | |
| IMSTSSSEAMSTPLM | 181 | Q8NET4 | |
| SSGVMSTEQMSATAS | 446 | Q8NET4 | |
| STQPVTATASETMSM | 511 | Q8NET4 | |
| TATASETMSMPQLTV | 516 | Q8NET4 | |
| QSMFSAPSSISSMTM | 211 | P78337 | |
| TAPATMSTAASGTTM | 321 | Q13554 | |
| AQSVMSMASSQISTD | 516 | Q96PX1 | |
| SMASSQISTDTVSSM | 521 | Q96PX1 | |
| GTTQTTSMPPEMSTT | 266 | Q9HDB5 | |
| EMSTTVMETTTTMAT | 276 | Q9HDB5 | |
| MLTITSIFSSSNMTV | 496 | Q7RTY7 | |
| SPMMNRTSDVTISSN | 1496 | O75376 | |
| ETNLMTTTEMPFTTS | 486 | Q8N695 | |
| TMATMSSAQLISAPS | 131 | Q15562 | |
| SISSMSMSSSMVPSA | 216 | Q99697 | |
| SSGQKITHVVSSTMM | 326 | Q8NEM2 | |
| VEMSTSVHSTEMVSV | 866 | Q9BZV3 | |
| AITMATTTPSPQMTS | 746 | P35712 | |
| SLVMTTTVSHNTTMP | 921 | Q8IZF2 | |
| ASSMTAASSTPMTLA | 151 | Q96F05 | |
| QMTGQISMTSVTSVP | 1406 | Q15596 | |
| MTSQSSVISNSCVTM | 1 | Q3ZCX4 | |
| MSDPQTSMAATAAVS | 1 | Q02086 | |
| ITMMTTQTSTMTFAP | 221 | Q9NVV0 | |
| SSSTTDAPTSSAMME | 156 | O94876 | |
| TSPVSTDSNMSAAVM | 1441 | Q9Y6N7 | |
| PESTIATSDVMSESM | 946 | Q12888 | |
| MDAVCTSTSPTRSMA | 196 | P20333 | |
| AVMEQGTSSSMTAES | 1671 | Q9Y3S1 | |
| IDETASDMSMSPQSS | 1571 | P31629 | |
| PTSDMEVSSSSVTTM | 586 | Q8NFY4 | |
| MEPSMQLESFSSSTS | 391 | Q5VUA4 | |
| LEQTVSMATTTQPMT | 551 | Q8WY91 | |
| ASDITSTSMSMPEHV | 121 | P08048 | |
| STSMSMPEHVLTSES | 126 | P08048 |